Bio-Techne
TECH
376 hedge funds and large institutions have $7.86B invested in Bio-Techne in 2019 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 120 increasing their positions, 120 reducing their positions, and 25 closing their positions.
172% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 25
45% more call options, than puts
Call options by funds: $2.11M | Put options by funds: $1.45M
12% more capital invested
Capital invested by funds: $7.05B → $7.86B (+$813M)
10% more funds holding
Funds holding: 341 → 376 (+35)
0% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 120
4.31% less ownership
Funds ownership: 380.27% → 375.96% (-4.3%)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$49.9M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$14.4M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$11.1M |
| 4 |
AAP
Aristotle Atlantic Partners
Sarasota,
Florida
|
+$11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
-$69.7M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$30.7M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$26.2M |
| 4 |
Janus Henderson Group
London,
|
-$22.2M |
| 5 |
Millennium Management
New York
|
-$15.2M |
TECH Hedge Fund Activity: Q4 2019 in Review
376 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2019, worth a combined $7.86B — up 12% from $7.05B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new TECH positions and 25 closed out — a net gain of 43 holders — while 120 added to existing stakes and 120 trimmed.
The largest buyer was Sumitomo Mitsui Trust Group, opening a new position worth an estimated $49.9M. The largest seller was 12 West Capital Management, exiting entirely with an estimated $69.7M sold.
- 376 institutional investors held Bio-Techne (TECH) as of Q4 2019, up from 341 in Q3 2019.
- Funds reported $7.86B of Bio-Techne stock for Q4 2019, up 12% quarter-over-quarter.
- 68 funds opened new Bio-Techne positions in Q4 2019 and 25 closed out, a net change of +43 holders.
- The largest Bio-Techne buyer in Q4 2019 was Sumitomo Mitsui Trust Group, an estimated $49.9M added.
- The largest Bio-Techne seller in Q4 2019 was 12 West Capital Management, an estimated $69.7M sold.
Based on aggregated 13F filings for Q4 2019.